Physician profile
Mark Edward Rea
NPI 1992849673
$8,570.79
in general payments reported to CMS, 2019-2025
23 companies · $1,780 in 2025
The $1,780 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $72.12 · 2021: $1,143 · 2022: $1,846 · 2023: $1,705 · 2024: $966 · 2025: $1,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,450.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,899.31 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $2,151.93 | 2019-2025 | Impella |
| Abbott Laboratories | $722.08 | 2019-2025 | Diamondback Coronary, Cardiomems |
| Stryker Corporation | $601.40 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Medtronic, INC. | $524.13 | 2021-2025 | Euphora, Onyx Frontier |
| Boston Scientific Corporation | $322.39 | 2023-2025 | Avvigo Guidance System, General - Stents, General - Therapies |
| Cardiovascular Systems INC. | $198.55 | 2019-2022 | |
| Shockwave Medical, INC | $187.17 | 2025 | |
| Angiodynamics, INC. | $183.92 | 2023-2025 | Angiovac, Alphavac, Angiodynamics |
| Medtronic Vascular, INC. | $128.15 | 2019 | |
| Atricure, INC. | $115.41 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Penumbra, INC. | $114.38 | 2019 | |
| Cardiva Medical, INC. | $97.72 | 2019-2024 | Optowire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.97 | 2019-2021 | |
| Terumo Medical Corporation | $62.50 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $35.93 | 2023-2024 | Mynx Control, Saber |
| W. L. Gore & Associates, INC. | $33.90 | 2024-2025 | Gore Cardioform Septal Occluder |
| Amgen INC. | $32.52 | 2020-2021 | |
| Genzyme Corporation | $20.05 | 2019 | |
| Biotronik INC. | $18.30 | 2022 | |
| Philips North America LLC | $15.19 | 2019 | |
| Bard Peripheral Vascular, INC. | $14.89 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.